Association of preferences for papillary thyroid cancer treatment with disease terminology: A discrete choice experiment
JAMA Otolaryngology—Head & Neck Surgery Nov 14, 2018
Nickel B, et al. - Experts sought to ascertain factors that influence treatment preferences for patients with papillary thyroid cancer (PTC), and trade-offs in treatment factors people are willing to accept, and to understand how terminology influences preferences and benefit-harm trade-offs. An important contribution was made by this study in understanding how attributes of treatment options, terminology, and patient characteristics, in particular, health literacy, influence treatment decision making for PTC.
Methods
- Authors assessed the preferences in PTC treatment using a discrete choice experiment (DCE) conducted as a web-based survey using an existing public online research panel.
- They randomized the participants to receive 1 of 2 frames of information based on the terminology used to describe the condition: “cancer” or “lesion.”
- The participants made a choice between 3 treatment options for PTC (thyroidectomy, hemithyroidectomy, and active surveillance).
- They conducted the analyses using a mixed logit model.
- Treatment preference was the main outcome variable; attributes of treatment options and sociodemographic characteristics were explanatory variables.
Results
- As per data, 2,054 participants (993 [48.3%] men and 1061 [51.7%] women; mean [SD] age, 46.0 [16.5] years) with no history of thyroid cancer completed the DCE.
- Options with less frequent follow-up, lower out-of-pocket costs, lower chances of having voice and calcium level problems, and a lower risk of developing invasive thyroid cancer and of dying of thyroid cancer were preferred by the participants.
- Results demonstrated that when trading benefits against harms, participants were willing to accept a higher number of extra patients experiencing adverse effects to avoid a thyroid cancer death when the condition was described as a cancer compared with a lesion.
- Specifically, more patients requiring lifelong medication (mean, 273; 95% CI, 207-339 vs mean, 98; 95% CI, 66-131), experiencing calcium problems (mean, 110; 95% CI, 77-144 vs mean, 56; 95% CI, 55-58), and fatigue (mean, 958; 95% CI, 691-1224 vs mean, 469; 95% CI, 375-564) were expected more willingly by the participants for whom the condition was described as a cancer.
- For both the cancer and lesion terminology, they noted a consistent association of health literacy with preferences for treatment options.
- A significantly lower preference for less invasive treatment options was seen in those with lower health literacy.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries